Endocrine-disrupting chemicals, or EDCs, are synthetic compounds that can mimic, block or scramble hormonal signaling. They are woven into modern life almost invisibly: bisphenol A (BPA) leaches from polycarbonate plastics, epoxy-can linings and thermal receipt paper; perfluorooctanoic acid (PFOA) belongs to the sprawling family of per- and polyfluoroalkyl substances, or PFAS, long used in nonstick cookware, water-repellent textiles and firefighting foams; di(2-ethylhexyl) phthalate (DEHP) softens vinyl products and medical tubing; the flame retardant BDE-209 sheds from consumer goods into household dust; the pesticide DDT, banned in most countries decades ago, persists in soils and fatty tissue; and the dioxin TCDD, an industrial byproduct, ranks among the most potent synthetic toxins ever characterized. Because the thyroid gland depends on precisely tuned hormonal feedback to regulate metabolism, growth and development, it is considered acutely vulnerable to such exposures. Global burden analyses have documented a steep, decades-long rise in thyroid cancer incidence, and while improved detection explains part of the trend, environmental contributors remain a live scientific concern. Epidemiological studies have linked several of these chemicals to thyroid dysfunction, nodules and cancer risk, yet the molecular steps that turn exposure into tumor progression have remained stubbornly opaque—precisely the gap the new study set out to close.

The Wuhan-led team began not at the laboratory bench but at the computer. They first ran all six chemicals—BPA, PFOA, DDT, BDE-209, TCDD and DEHP—through ADMETlab 3.0, a machine-learning web platform that predicts a compound’s absorption, distribution, metabolism, excretion and toxicity directly from its molecular structure, providing a standardized read on how hazardous each molecule is likely to be. They then mined the Comparative Toxicogenomics Database, a curated public repository that logs which genes have been experimentally shown to respond to which chemicals. In parallel, the researchers compiled lists of genes implicated in thyroid cancer from multiple disease databases. Overlaying the chemical-response gene sets with the cancer gene sets produced a shared space of 1,113 EDC–thyroid cancer targets: genes that both respond to endocrine-disrupting chemicals and participate in malignant thyroid disease.

To give that list biological meaning, the team performed pathway enrichment analysis, a statistical method that tests whether a set of genes clusters within particular signaling networks more densely than chance would predict. The 1,113 shared targets concentrated strikingly in three circuits. The PI3K–Akt pathway, a core growth-control cascade promoting cell survival, proliferation and metabolism, is among the most frequently dysregulated networks in human cancer. The FoxO transcription factor family acts downstream of Akt and governs cell-cycle arrest, DNA repair, apoptosis and oxidative-stress resistance—functions of special relevance in the thyroid, where hormone synthesis inherently generates reactive oxygen species. The AGE–RAGE axis, which couples advanced glycation end products to their cell-surface receptor RAGE, sustains chronic inflammatory signaling and has previously been implicated in the migratory behavior of thyroid cancer cells. Convergence of EDC-responsive genes on these pro-growth, pro-survival, pro-inflammatory circuits handed the researchers their first mechanistic hypothesis: chemical exposure may be rewiring the very pathways that decide whether a thyroid tumor grows, spreads or dies.

The next question was which of those 1,113 genes actually separate tumor tissue from healthy thyroid. Differential expression analysis of transcriptomic datasets filtered the candidates down to genes consistently dysregulated in cancer, and the shortlist then went to machine learning. The team applied least absolute shrinkage and selection operator (Lasso) regression, an algorithm that penalizes model complexity and drives the coefficients of uninformative genes to exactly zero, compressing hundreds of features into a minimal signature. The surviving genes were classified with linear discriminant analysis (LDA), a supervised method that separates patient groups along an optimal linear boundary. The resulting six-gene diagnostic model—FN1, which encodes the extracellular-matrix protein fibronectin; BCL2, a canonical anti-apoptotic gene; CD44; CDKN1A, which encodes the cell-cycle brake p21; CTNNB1, the gene for β-catenin at the core of WNT signaling; and JUN, a pillar of the AP-1 transcription factor—achieved an average area under the receiver operating characteristic curve (AUC) of 0.976 across a training cohort and three independent validation cohorts. An AUC of 1.0 signifies perfect discrimination and 0.5 mere coin-flipping, so a value nearing 0.98 represents diagnostic performance close to clinical grade.

Within that six-gene panel, one name kept rising to the top. Evaluated alone, CD44 achieved AUC values of 0.950 in the training set, 0.801 in the external dataset GSE27155, 0.878 in GSE29265 and 0.938 in GSE153659—performance that persisted across cohorts generated by different laboratories on different platforms, a robustness that matters because datasets built independently are far less likely to share hidden technical biases. To understand why the algorithm leaned so heavily on this gene, the researchers deployed SHAP analysis, short for SHapley Additive exPlanations, a game-theoretic framework borrowed from economics that distributes the credit for every prediction among the features that produced it. In the SHAP ranking, CD44 made the largest single contribution to the model’s output, evidence that the machine had not latched onto a statistical artifact but onto the gene that best captured the boundary between tumor and healthy tissue.

CD44 is no obscure molecule. It encodes a transmembrane glycoprotein that serves as the principal cell-surface receptor for hyaluronic acid, the gel-like polymer filling the space between cells, and through that interaction it governs adhesion, migration and invasion. It is a defining marker of cancer stem cells—the self-renewing subpopulation thought to seed relapse and shrug off therapy—and has been tied to progression and metastasis across many tumor types, including papillary thyroid carcinoma. The new study layered further dimensions onto that profile. Immune infiltration analysis indicated that CD44 expression covaries with the makeup of the tumor immune microenvironment, the mix of macrophages, T cells and other immune players surrounding a growing tumor. Survival analysis of data from The Cancer Genome Atlas linked CD44 levels to patient prognosis, and single-cell RNA sequencing positioned the gene as a marker of shifting cellular states within malignant cells. Taken together, these analyses cast CD44 as sitting at the junction where environmental stress, tumor identity and immune context meet.

The most provocative question was whether the chemicals themselves can physically engage CD44. To probe it, the team used molecular docking, a computational technique that fits flexible small molecules into the three-dimensional structure of a protein’s binding region and scores how well each one lodges there. Docking produced plausible binding poses for BPA, DEHP and PFOA on CD44, with PFOA—the eight-carbon fluorinated compound infamous for its nearly unbreakable carbon–fluorine backbone—returning the most favorable predicted docking score. The researchers then stress-tested each protein–ligand complex with 200-nanosecond molecular dynamics simulations, which track every atom of the pair in a simulated water environment and reveal whether an interaction holds together or falls apart over realistic molecular timescales. The complexes remained plausible across the simulated run, supporting—though not yet proving—direct physical contact between these environmental chemicals and the CD44 protein. The authors are careful with language here: docking scores and simulated stability are computational hypotheses that will need confirmation by direct biophysical measurements such as surface plasmon resonance or calorimetry.

Computational hypotheses were not the endpoint. In the laboratory, the team confirmed that CD44 is expressed at higher levels in thyroid cancer tissues and thyroid cancer cell lines than in normal counterparts. When the cells were exposed to endocrine-disrupting chemicals, CD44 expression climbed further. The decisive experiment followed: using molecular tools to knock down CD44—silencing the gene so its protein is no longer made—the researchers showed that the gains in proliferation, colony formation and migration that ordinarily follow EDC exposure were substantially attenuated. Colony-forming assays, which measure how many single cells can found entire colonies, and migration assays, which track how quickly cells close a wound-like gap or invade through a membrane, are standard readouts of malignant potential. In effect, the experiment closed a loop: chemical exposure raises CD44, elevated CD44 licenses aggressive behavior, and removing CD44 strips much of that behavior away.

The authors frame CD44 as a candidate target associated with EDC-responsive malignant phenotypes in thyroid cancer—a deliberately measured formulation that reflects both the strength and the limits of the evidence. The study does not claim that endocrine-disrupting chemicals initiate thyroid cancer, and a docking score is not a demonstrated drug-like interaction. What it does establish is a coherent, multi-layered chain of evidence: computational toxicity profiling, toxicogenomic mining, pathway convergence, a near-clinically accurate six-gene diagnostic model, single-gene robustness across independent cohorts, microenvironmental and single-cell corroboration, structural simulation, and finally laboratory intervention. If future work confirms direct CD44 binding by these chemicals in living systems and validates the diagnostic panel in prospective patient cohorts, the implications are considerable, because CD44 is already pursued as an oncology target through antibodies and hyaluronan-based drug delivery strategies, offering a plausible road from biomarker to intervention. In the meantime, the study adds molecular weight to a public-health argument that has been building for years: curbing exposure to endocrine-disrupting chemicals is not merely an endocrine issue—it may be an oncological one.

Microalgae have gained attention for their unique ability to biologically transform and remove pollutants from aquatic environments. This natural capability makes them not only valuable for wastewater treatment but also for the bioremediation of toxic compounds like environmental estrogens. Studies indicate that certain microalgae species may effectively absorb these pollutants, thereby reducing their concentration in contaminated waterbodies. Moreover, the metabolic processes inherent to microalgae can lead to the degradation of complex molecules into less harmful byproducts, presenting a dual approach for remediation and toxin reduction.

The integration of bacteria with microalgae in treatment systems can catalyze this process further, as these consortia can enhance the degradation pathways of environmental estrogens. Bacteria can break down complex organic matter, which can support the growth of microalgae, creating a synergistic relationship that improves overall treatment efficiency. This symbiotic effect not only enhances pollutant removal rates but also fosters microbial diversity, which is crucial for sustaining ecosystem resilience.

Indeed, the review conducted by da Silva and Mounteer delves deeply into this cutting-edge intersection of microbiology and environmental chemistry, examining how these biotechnological solutions can be harnessed. The researchers underscore the significance of selecting appropriate microalgal species, as their varying capabilities for uptake and biodegradation play critical roles in the effectiveness of these systems. Understanding the biology and physiological characteristics of microalgae can lead to optimized methodologies for utilizing them in real-world applications.

One promising avenue explored is the selection of microalgae based on their specific biochemical compositions. Some species are naturally equipped with higher lipid and carbohydrate content, which can further facilitate the breakdown of pollutants. For instance, studies have demonstrated that certain strains can effectively bioaccumulate heavy metals alongside organic pollutants, underscoring their multifunctional potential in environmental remediation. Furthermore, the genetic manipulation of microalgae presents an exciting frontier, wherein researchers can enhance specific pathways to increase the organism’s pollutant breakdown capabilities.

A critical aspect of this research is the evaluation of system scalability. Laboratory-scale experiments often yield impressive results, yet translating these findings into larger, practical applications remains a challenge. Parameters such as nutrient availability, water chemistry, and environmental conditions can significantly influence the performance of microalgae and microbial consortia. Addressing these factors will be essential for implementing successful bioremediation systems in diverse ecosystems, from industrial wastewater treatment plants to natural bodies of water.

While microalgae and their associated bacteria present promising solutions, there are still hurdles to overcome in the regulatory landscape. The introduction of biological agents into ecosystems raises concerns regarding potential ecological impacts, necessitating rigorous assessment protocols. Regulatory frameworks will need to adapt to encompass the nuances of biotechnology applications in environmental remediation. This effort could ensure that innovative solutions are adopted responsibly while safeguarding public and ecological health.

Moreover, public perception of bioremediation technologies can influence their implementation. Education plays a crucial role in fostering acceptance of these solutions within communities often concerned about environmental interventions. Demonstrating the effectiveness, safety, and benefits of using microalgae and bacteria in tackling pollution can help shift perspectives and encourage stakeholders to embrace eco-friendly technologies.

Additionally, interdisciplinary collaboration will be vital in advancing these solutions. Partnerships between scientists, policymakers, and industries can facilitate the exchange of knowledge and resources necessary to refine and deploy microalgae-based systems effectively. Collaborative research initiatives can also broaden the scope of studies to include not only pollutant removal but also the potential for resource recovery, such as biofuels or valuable bioproducts generated from treated effluent.

Finally, as environmental estrogens continue to emerge as a pressing concern globally, the urgency for comprehensive solutions is more critical than ever. The synthesis of microbial science and environmental engineering offered by the integration of microalgae and bacteria represents a promising pathway toward mitigating the impacts of these harmful substances. By advancing research in this field, we can pave the way for a cleaner, safer environment, benefiting both humans and wildlife alike.

The findings presented by da Silva and Mounteer serve as a clarion call to the scientific community and beyond, underscoring the potential of harnessing biological processes in tackling some of today’s most challenging environmental issues. As these innovative treatments gain traction, they may well reshape the conversation around pollution, sustainability, and our responsibility towards the natural world.

In conclusion, as we explore these biological treatment systems, we must remain vigilant about the ongoing challenges posed by environmental estrogens and their complex interactions within ecosystems. The proactive adoption of microalgae and their bacterial partners as formidable allies in the fight against pollution is not just an exciting prospect but a necessary approach in our quest for sustainable environmental management.

Subject of Research:
Environmental estrogens and their removal using microalgae and microalgae-bacteria consortia.

Article Title:
Removal of environmental estrogens and estrogenic activity by microalgae and microalgae-bacteria consortia: an integrative review.

Article References:

da Silva, P.R., Mounteer, A.H. Removal of environmental estrogens and estrogenic activity by microalgae and microalgae-bacteria consortia: an integrative review.
Environ Sci Pollut Res (2025). https://doi.org/10.1007/s11356-025-37020-z

Image Credits: AI Generated

DOI:

Keywords: Environmental estrogens, microalgae, bioremediation, pollution, sustainability, endocrine disruptors.

The introduction of advanced nanomaterials for environmental remediation marks a significant breakthrough in addressing water contamination issues. MWCNTs are known for their impressive surface area, mechanical strength, and electrical conductivity, making them excellent candidates for adsorbents. The researchers have taken this a step further by functionalizing these nanotubes with iron nanoparticles, which significantly enhances their adsorptive properties for toxic compounds like BPA.

BPA has been detected in various waterways around the globe, raising alarm among public health officials and environmentalists alike. As a result, there has been a heightened need for effective treatment methods to remove this compound from wastewater. Traditional methods, such as biological degradation and chemical oxidation, often fall short, leaving a gap that innovative technologies like iron nanoparticle-functionalized MWCNTs can potentially fill.

The process of functionalization is crucial to the performance of MWCNTs. By incorporating iron nanoparticles onto the surface of these nanotubes, researchers have been able to significantly increase the binding sites available for BPA molecules, thus enhancing the overall adsorption capacity. The enhanced reactivity and surface properties of the modified MWCNTs allow for a more effective capture of BPA, transforming them into a viable option for water treatment systems.

In conducting their experiments, the researchers meticulously measured the adsorption isotherms of BPA onto the iron-functionalized MWCNTs to evaluate their efficiency. These measurements are pivotal in understanding how well the nanotubes bond with BPA molecules under different conditions, including variations in pH and temperature. The findings have the potential to inform practical applications in large-scale water treatment facilities that are grappling with similar contaminants.

Additionally, the use of iron nanoparticles also introduces magnetic properties to the MWCNTs, which allows for easy separation and recovery post-treatment. This feature is critically important for industrial applications where ease of recycling and reduced waste are essential operational considerations. Once the treatment process is completed, the MWCNTs can be removed using magnetic fields, thus minimizing potential secondary pollution.

The research sheds light on the mechanistic aspects of how BPA molecules interact with the functionalized MWCNTs. The team discovered that not only do the MWCNTs adsorb BPA strongly, but they also demonstrate remarkable selectivity for this pollutant, effectively separating it from other organic molecules present in wastewater. Understanding these interactions in more detail could lead to engineered solutions that specifically target a range of contaminants, thus advancing the field of water purification technology.

Moreover, the innovation presented by da Cruz and colleagues could ultimately pave the way for the development of new filtration systems that leverage MWCNTs with iron nanoparticles. Such systems could be incorporated into existing water treatment infrastructures or established as standalone units designed to specifically combat BPA contamination, thereby providing a targeted solution in the global effort to maintain clean water supplies.

The study results could spark interest among businesses and environmental agencies, prompting discussions about how to implement these advanced materials within current remediation practices. As the world grapples with increasing pollution levels, the significance of developing practical and efficient solutions to mitigate contaminants like BPA cannot be overstated. The potential adoption of these technologies could lead to widespread improvements in how communities manage their water resources.

Furthermore, considering the regulatory pressures to minimize BPA exposure among the public, the applications of iron nanoparticle-functionalized MWCNTs underscore a proactive approach to environmental health. By critically addressing the sources of this hazardous chemical, the impact of BPA-related health issues could be significantly reduced. This research reflects a commitment to science that seeks not only to innovate but to ensure the safety and health of the global population.

As we progress toward a more sustainable future, the exploration of nanotechnology and functional materials will undoubtedly play a pivotal role. The transformative potential of MWCNTs, particularly when enhanced with iron nanoparticles, illustrates the exciting avenues available for researchers focused on tackling environmental challenges. This study not only adds to the growing body of knowledge surrounding nanoscale materials but also highlights the collaborative efforts needed across disciplines to conquer some of the most pressing issues of our time.

In conclusion, the research conducted by da Cruz and his team exemplifies the continuous integration of nanotechnology into environmental applications. With ongoing advancements in material science, we stand at the forefront of revolutionizing how we approach pollution and water purification. Their findings bring to light a promising direction for future research and application in developing cleaner, safer water supply systems for generations to come, urging the scientific community and policymakers alike to take these findings seriously in their quest to protect public health and the environment.

Subject of Research: Adsorptive behavior of multi-walled carbon nanotubes functionalized with iron nanoparticles for bisphenol A removal.

Article Title: Adsorptive behavior of multi-walled carbon nanotubes functionalized with iron nanoparticles for bisphenol A removal.

Article References: da Cruz, R.R., da Silva, T.L., da Silva, M.G.C. et al. Adsorptive behavior of multi-walled carbon nanotubes functionalized with iron nanoparticles for bisphenol A removal. Environ Sci Pollut Res (2025). https://doi.org/10.1007/s11356-025-36923-1

Image Credits: AI Generated

DOI: 10.1007/s11356-025-36923-1

Keywords: bisphenol A, multi-walled carbon nanotubes, iron nanoparticles, adsorption, water treatment, environmental remediation, nanotechnology.

Endocrine disrupting chemicals are synthetic or natural compounds that interfere with the body’s hormonal systems, a critical mechanism governing growth, metabolism, and reproduction. These chemicals are ubiquitously present in everyday materials—from plastics and cosmetics to food packaging and pesticides. Their omnipresence exacerbates human exposure risks, which research links to a spectrum of adverse health outcomes including infertility, metabolic disorders like obesity and diabetes, certain cancers, and neurodevelopmental conditions such as autism spectrum disorders. The pervasive and insidious nature of EDCs reflects a critical environmental health issue requiring focused scientific scrutiny and regulatory reform.

The complexity of identifying and regulating EDCs stems in part from their vast chemical diversity and subtle biological effects, often manifesting at low doses with non-traditional dose-response relationships. Furthermore, the persistence and bioaccumulative characteristics of many EDCs, particularly so-called "forever chemicals," complicate risk assessment and regulatory oversight. Perfluoroalkyl and polyfluoroalkyl substances (PFAS), a notorious subset of these persistent pollutants, persist indefinitely in the environment and have been detected in numerous contamination hotspots across Europe, including Denmark. Such persistence amplifies concerns about long-term population exposure, especially in vulnerable communities.

Europe faces a significant regulatory challenge given the staggering number of chemicals in commercial circulation. According to estimates from the European Environment Agency, the market contains approximately 100,000 chemicals, yet around 70% of these lack comprehensive toxicological evaluation regarding their endocrine-disrupting potential. This data gap underscores an urgent need for advanced scientific methodologies to identify hazardous substances and enforce protective regulatory frameworks that prioritize human and environmental health. Without targeted intervention, the silent burden of chemical exposure will continue to exacerbate chronic disease prevalence and environmental degradation.

The timing of the Copenhagen event is strategically aligned with Denmark’s impending EU Council Presidency beginning in July 2025. This leadership role offers Denmark a unique platform to steer European chemical policy towards more robust protections against EDCs. By fostering dialogue between cutting-edge scientists and policymakers, the event aims to accelerate transformation in chemical regulation inspired by the latest scientific evidence, facilitating policies that effectively mitigate exposure risks and promote public health equity across Europe.

Speakers at the event will include an array of distinguished experts from both the scientific and political realms. These include European parliamentarians, national policymakers, and researchers who specialize in endocrine disruption, chemical safety, and public health. The program is designed to integrate recent scientific advances from the Joint Congress of ESPE and ESE 2025 with actionable policy recommendations, emphasizing translational science that bridges laboratory findings with societal impact.

Scientific sessions will delve into key research outcomes, underscoring vital priorities outlined in the EndoCompass Research Roadmap—an ambitious project designed to enhance the understanding of endocrine disruptors’ health effects and guide future investigations. By focusing on mechanistic studies, biomarker development, and toxicological characterization, the roadmap aims to fill existing knowledge gaps and enable risk assessors to better predict and prevent adverse outcomes associated with chemical exposure.

Equally significant is the public health and policy-oriented segment of the event, which will examine strategies to reduce EDC exposure in susceptible populations, particularly pregnant women and children. Given the critical periods of development during gestation and early childhood when endocrine systems are highly sensitive, minimizing chemical exposures during these windows is paramount. Discussions will emphasize evidence-based interventions, regulatory tightening, and community engagement to safeguard vulnerable demographics.

A notable highlight will be the presentation of New Approach Methodologies (NAMs), which represent innovative, non-animal testing techniques leveraging in vitro systems, computational models, and high-throughput screening to assess chemical toxicity. NAMs hold promise for revolutionizing EDC assessment by expediting hazard identification, reducing reliance on traditional animal studies, and providing mechanistic insights into endocrine disruption pathways. This paradigm shift in toxicology is essential to keeping pace with the vast number of chemicals requiring evaluation.

The event will also include a powerful testimonial from local communities in Denmark affected by PFAS contamination, providing essential real-world context to the scientific and policy discussions. Hearing firsthand accounts from individuals living with the consequences of chemical exposure adds urgency and humanizes the scientific discourse, compelling policymakers to consider the ethical imperative of prompt regulatory action.

After the formal sessions, attendees can engage in a networking lunch and a press question-and-answer segment, fostering collaborative exchange among scientists, policymakers, media representatives, and civil society actors. This interaction is intended to galvanize a multifaceted response to endocrine disruption, ensuring that the momentum generated at the event translates into tangible advances in chemical safety regulation and public health protection.

In summary, the Copenhagen Legacy Event symbolizes a pivotal juncture in Europe’s approach to endocrine disruptors. It combines rigorous scientific insight with proactive policy dialogue, strategically positioned to influence regulatory agendas during Denmark’s EU Council Presidency. As the evidence mounts regarding the pervasive risks of EDCs, this convening represents a clarion call for coordinated, science-driven action to mitigate chemical hazards, protect vulnerable populations, and pave the way toward a healthier environment for present and future generations.

Subject of Research: Endocrine Disrupting Chemicals and Their Impact on Health and Environment
Article Title: Europe’s Scientific and Policy Leaders Unite to Confront Endocrine Disrupting Chemicals Threat
News Publication Date: Not specified
Web References:

• https://espe-ese-congress2025.org/legacy-event-14-may/
• https://www.lemonde.fr/en/les-decodeurs/article/2023/02/23/forever-pollution-explore-the-map-of-europe-s-pfas-contamination_6016905_8.html
• https://joint-research-centre.ec.europa.eu/jrc-news-and-updates/transforming-eu-chemicals-regulation-better-protect-human-health-and-environment-2023-12-11_en
  Image Credits: European Society of Endocrinology
  Keywords: Endocrine disruptors, endocrine system, hormones, endocrinology, ecotoxicology, endocrine diseases, environmental illness, infertility